Related Experiment Video
Updated: May 8, 2026
08:40
Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Genetic variants associated with Crohn's disease.
Sonia Michail1, Gilberto Bultron, R William Depaolo
1The University of Southern California, Children's Hospital of Los Angeles, Los Angeles, CA, USA.
The Application of Clinical Genetics
|August 13, 2013
Summary
Crohn's disease involves gastrointestinal inflammation due to genetic, microbial, and environmental factors. Genetic variants, particularly NOD2/CARD15, impact disease course and prognosis, offering insights into pathophysiology.
Area of Science:
- Gastroenterology
- Immunology
- Genetics
Background:
- Crohn's disease is a chronic immune disorder causing gastrointestinal inflammation.
- Etiology involves microbial, immunological, and environmental factors in genetically susceptible individuals.
- The immune system mistakenly attacks the intestine, cross-reacting with gut microbial antigens.
Purpose of the Study:
- To review recent advances in understanding genetic variants in Crohn's disease.
- To explore how these genetic variants influence disease progression and patient outcomes.
- To highlight the role of microbial recognition genes, such as NOD2/CARD15.
Main Methods:
- Literature review of genetic studies in Crohn's disease.
- Analysis of the association between genetic variants and disease pathophysiology.
- Examination of the impact of specific genes on disease course and prognosis.
Main Results:
- Numerous genetic variants are linked to Crohn's disease.
- Many variants affect genes involved in microbial recognition and bacterial wall sensing.
- The NOD2/CARD15 gene is the most commonly implicated genetic factor.
Conclusions:
- Genetic variants play a significant role in Crohn's disease development and presentation.
- Understanding these genetic factors enhances knowledge of disease pathophysiology.
- Genetic insights are crucial for predicting disease course and prognosis in Crohn's disease patients.
Related Concept Videos
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
02:26Comparing Copy Number Variations and SNPs
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...